Mangalam Drugs and Organics Share Price

    NSE
    90.66
    +1.66 (1.12%)
    MANGALAM • 11 Jul, 2025 | 09:37 AM
    BUY

    1Y Annualised Return

    -19.00%

    3Y Annualised Return

    -16.26%

    5Y Annualised Return

    6.04%

    The current prices are delayed, login or Open Demat Account for live prices.

    Mangalam Drugs and Organics Stock Performance

    1W Return6.66
    1Y Return-17.65
    Today's Low88.9
    Prev. Close89.00
    Mkt Cap (Cr.)140.87
    1M Return8.38
    3Y Return-40.35
    52-Week High144.99
    Open88.90
    PE Ratio20.31
    6M Return-18.74
    Today's High90.5
    52-Week Low70.1
    Face Value10

    Mangalam Drugs and Organics Company background

    Founded in: 1972
    Managing director: Govardhan M Dhoot
    Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001. The company was promoted by Dhoot family. The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals.The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an inhouse Research and Development (RD) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries.In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company. In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine. In the year 20032004, the bulk drug production capacity of the Company was increased from 350 MTPA to 600 MTPA. During the 200405, the capacity is being further enhanced to 960 MTPA. During the year 200506, the company further enhanced their Bulk drug production capacity from 960 MT per annum to 1260 MT per annum.During the year 200708, the company developed and introduced new bulk drugs namely Bisoprolol Fumarate and Pantaprazole Sodium. Also, they increased the production capacity of Meta Chloro Aniline Allied Products from 250 tons to 350 tons.During the year 200910, the company in addition to Regulatory Affairs Cell established Intellectual Property Rights (IPR) cell. The regulatory affairs cell submitted 6 DMFs to WHOGeneva out of which 2 DMFs corresponding to Artemether and Lumefantrine had been approved.During the year 201718, Unit 2 of the Company received WHO Approvals for manufacturing of the Active Pharmaceutical ingredients comprising of Lumefantrine (APIMF100) Tenofovir Disoproxil Fumarate (APIMF204) Artemether (APIMF138) Emtricitabine (WHO API314) Efavirenz (WHO API 318).

    As of 11 Jul, 2025, Mangalam Drugs and Organics share price is ₹90.5. The stock opened at ₹88.9 and had closed at ₹89 the previous day. During today’s trading session, Mangalam Drugs and Organics share price moved between ₹88.90 and ₹90.50, with an average price for the day of ₹89.70. Over the last 52 weeks, the stock has recorded a low of ₹70.10 and a high of ₹144.99. In terms of performance, Mangalam Drugs and Organics share price has declined by 18.7% over the past six months and has declined by 19% over the last year.

    Read More
    Mangalam Drugs and Organics SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹59,17,456 (-8.96%)
    Daily SIP of 25,000 would have become 59,17,456 in 1 year with a gain of -5,82,543 (-8.96%)
    View details of Market Depth

    Mangalam Drugs and Organics Fundamental

    Market Cap (in crs)

    140.87

    Face Value

    10

    Turnover (in lacs)

    2.09

    Key Metrics

    Qtr Change %
    37.59% Fall from 52W High
    21.3
    Dividend yield 1yr %
    0

    Mangalam Drugs and Organics Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Mangalam Drugs and Organics Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    73.04 Cr
    88.71 Cr
    79.94 Cr
    76.54 Cr
    102.24 Cr
    Mangalam Drugs and Organics Yearly Revenue
    Mar 2025Mar 2024Mar 2022Mar 2021
    318.73 Cr
    368.69 Cr
    533.48 Cr
    303.32 Cr
    Mangalam Drugs and Organics Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    0.06 Cr
    1.29 Cr
    2.69 Cr
    2.68 Cr
    3.53 Cr
    Mangalam Drugs and Organics Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2022Mar 2021
    6.72 Cr
    -9.07 Cr
    12.31 Cr
    2.65 Cr

    Mangalam Drugs and Organics Result Highlights

    • Mangalam Drugs and Organics Ltd reported a 15.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.

    • Its expenses for the quarter were up by 12.4% QoQ and - - YoY.

    • The net profit increased 173.6% QoQ and - - YoY.

    • The earnings per share (EPS) of Mangalam Drugs and Organics Ltd stood at 2.2 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Mangalam Drugs and Organics

    Promoter
    50.3%
    Foreign Institutions
    0.5%
    Public
    49.2%
    Promoter
    50.3%
    Foreign Institutions
    0.1%
    Public
    49.6%
    Promoter
    50.3%
    Foreign Institutions
    0.1%
    Public
    49.6%
    Promoter
    50.3%
    Foreign Institutions
    0.2%
    Public
    49.5%
    Promoter
    50.3%
    Foreign Institutions
    0.3%
    Public
    49.4%
    Promoter
    50.3%
    Foreign Institutions
    0.1%
    Public
    49.6%

    Mangalam Drugs and Organics Technical Analysis

    Moving Averages Analysis
    90.66
    Current Price
    Bullish Moving Averages
    13
    Bearish Moving Averages
    3
    5Day EMA
    88.30
    10Day EMA
    86.20
    12Day EMA
    85.60
    20Day EMA
    84.00
    26Day EMA
    83.30
    50Day EMA
    82.60
    100Day EMA
    86.00
    200Day EMA
    93.30
    5Day SMA
    88.50
    10Day SMA
    85.10
    20Day SMA
    82.60
    30Day SMA
    82.30
    50Day SMA
    80.70
    100Day SMA
    82.90
    150Day SMA
    92.60
    200Day SMA
    98.20
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    23524 Rs
    43408 Rs
    Week Rs
    66119 Rs
    141886 Rs
    Month Rs
    32388 Rs
    60542 Rs
    90.10
    Pivot
    Resistance
    First Resistance
    91.99
    Second Resistance
    94.98
    Third Resistance
    96.87
    Support
    First Support
    87.11
    Second support
    85.22
    Third Support
    82.23
    Relative Strength Index
    67.75
    Money Flow Index
    64.46
    MACD
    2.21
    MACD Signal
    1.17
    Average True Range
    3.63
    Average Directional Index
    26.04
    Rate of Change (21)
    6.60
    Rate of Change (125)
    -21.56

    Mangalam Drugs and Organics Latest News

    09 JUL 2025 | Wednesday

    Mangalam Drugs & Organics Ltd - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    09 JUL 2025 | Wednesday

    Mangalam Drugs & Organics Ltd - 532637 - Corporate Action-Updates on Amalgamation/ Merger / Demerger

    27 JUN 2025 | Friday

    Mangalam Drugs & Organics Ltd - 532637 - Closure of Trading Window

    View More

    Mangalam Drugs and Organics Share Price FAQs

    Mangalam Drugs and Organics share price is ₹90.66 in NSE and ₹90.68 in BSE as on 11/7/2025.

    Mangalam Drugs and Organics share price in the past 1-year return was -17.64. The Mangalam Drugs and Organics share hit a 1-year low of Rs. 70.1 and a 1-year high of Rs. 144.99.

    The market cap of Mangalam Drugs and Organics is Rs. 140.87 Cr. as of 11/7/2025.

    The PE ratios of Mangalam Drugs and Organics is 20.3 as of 11/7/2025.

    The PB ratios of Mangalam Drugs and Organics is 0.94 as of 11/7/2025

    You can easily buy Mangalam Drugs and Organics shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Mangalam Drugs and Organics share price is ₹144.99 and ₹70.1 as of 11/7/2025.

    Please be aware that Mangalam Drugs and Organics stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    66.10
    +0.13 (+0.20%)
    137.05
    -0.08 (-0.06%)
    694.30
    -1.30 (-0.19%)
    2,586.00
    +5.00 (+0.19%)
    161.76
    -7.88 (-4.65%)
    383.70
    -1.00 (-0.26%)
    161.04
    +0.38 (+0.24%)
    261.10
    -1.75 (-0.67%)
    412.50
    -1.00 (-0.24%)
    400.65
    +0.75 (+0.19%)
    Top Gainers
    2,512.00
    +103.60 (+4.30%)
    1,101.10
    +12.20 (+1.12%)
    1,828.10
    +17.90 (+0.99%)
    2,424.20
    +22.80 (+0.95%)
    1,174.20
    +9.90 (+0.85%)
    Top Losers
    3,320.70
    -61.30 (-1.81%)
    260.95
    -4.10 (-1.55%)
    1,591.50
    -24.30 (-1.50%)
    3,116.00
    -46.40 (-1.47%)
    669.50
    -5.55 (-0.82%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -